Spanish pharma firm, ROIS, enters Phoenix market after deal with Bristol Myers Squibb

  • 4/3/2026

|

Phoenix Business Journal

|

Paywall icon
• Subcategory:
• Additional Filters-Subcategory:
• Additional Filters-Tags: ,

Highlights
ROVI Pharma Industrial Services bought a Phoenix plant for $18,524,000
The five-year agreement guarantees ROVI $50 million in annual revenue
Bristol Myers Squibb invested $100 million into the manufacturing site

ROIS (ROVI Pharma)
Javier López-Belmonte | Vice Chairman of the Board and CFO

Additional Filters

Subcategory
Tags